Is BMRN stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 21st of November 2014, BioMarin Pharmaceutical had a stock price of $85.83. If you invested back then, your return now would be a loss of $-23.27 per share or -27.11%
Yes, the average daily trading liquidity for BioMarin Pharmaceutical is $125.62 million. You should therefore be able to get in and out of your positions relatively fast.
BioMarin Pharmaceutical has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.69, the company's ability to pay off the debt is good. BioMarin Pharmaceutical has a good net profit margin of 11.77% and should have high tolerances against inflation.
We have calculated the inflation risk for BioMarin Pharmaceutical to be low [0.1 out of 1]